Neonatal haemoglobinopathy screening in Burkina Faso

J Clin Pathol. 2009 Jan;62(1):39-41. doi: 10.1136/jcp.2008.058966.

Abstract

Aims: To report our experience of neonatal screening for sickle cell disease in Ouagadougou (Burkina Faso) and to discuss the feasibility of neonatal screening in this country.

Methods: Between the years 2000 and 2004, there were about 2,341 births in five maternity services in Ouagadougou. These babies were screened for sickle cell disease in a universal screening pilot programme. In 2006, 53 babies born to selected couples were screened. The specimens were collected either by cord blood sampling or from a dried blood spot on filter paper. The screening was performed using an isoelectric focusing technique.

Results: In the first stage (2000-4), the incidence of sickle cell disease was 1:57. In the second stage, six of 53 babies of selected couples were found to have major haemoglobinopathies: one was homozygous for haemoglobin S and five were compound heterozygotes for haemoglobins S and C.

Conclusions: The results suggest that a national screening programme should be implemented in Burkina Faso with effective newborn and subsequent follow-up, but a methodology needs to be developed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Burkina Faso / epidemiology
  • Developing Countries
  • Feasibility Studies
  • Hemoglobinopathies / diagnosis*
  • Hemoglobinopathies / epidemiology
  • Humans
  • Infant, Newborn
  • Isoelectric Focusing
  • Neonatal Screening / methods*
  • Outcome Assessment, Health Care